Chiesi has proven its dedication to global public health through its designation as a certified Benefit Corporation (B Corp) since 2019. And the company lives its commitment to patient centricity ...
In a dramatic change in fortunes, Novartis has won a major victory in its bid to defend oral multiple sclerosis therapy Gilenya from early generic competition in the US. Things have been looking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback